*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Du/NNP Pont/NNP Co./NNP ]
,/, seeking/VBG to/TO 
[ speed/VB ]
to/TO 
[ market/NN ]

[ some/DT ]
of/IN 
[ its/PRP$ more/JJR promising/JJ drug/NN candidates/NNS ]
,/, entered/VBD 
[ a/DT research/NN ]
and/CC 
[ marketing/NN pact/NN ]
with/IN 
[ Merck/NNP ]
&/CC 
[ Co/NNP ]
./. 

======================================

[ Du/NNP Pont/NNP ]
and/CC 
[ Merck/NNP ]
will/MD collaborate/VB in/IN developing/VBG 
[ a/DT class/NN ]
of/IN 
[ compounds/NNS ]
for/IN treating/VBG 
[ high/JJ blood/NN pressure/NN ]
and/CC 
[ heart/NN disease/NN ]
,/, called/VBN 
[ angiotensin/NN II/CD receptor/NN antagonists/NNS ]
./. 

[ The/DT two/CD companies/NNS ]
also/RB will/MD market/VB 
[ the/DT compounds/NNS ]
together/RB ,/, if/IN 
[ regulators/NNS ]
grant/VBP 
[ marketing/NN approval/NN ]
./. 

In/IN 
[ addition/NN ]
,/, 
[ Du/NNP Pont/NNP gains/VBZ ]
marketing/NN 
[ rights/NNS ]
to/TO 
[ two/CD ]
of/IN 
[ Merck/NNP 's/POS established/JJ prescription/NN drugs/NNS ]
./. 

======================================

For/IN 
[ Du/NNP Pont/NNP ]
,/, 
[ the/DT agreement/NN ]
represents/VBZ 
[ an/DT attempt/NN ]
to/TO accelerate/VB 
[ the/DT payoff/NN ]
from/IN 
[ its/PRP$ ambitious/JJ ]
but/CC 
[ expensive/JJ push/NN ]
into/IN 
[ pharmaceuticals/NNS ]
./. 

[ Merck/NNP ]
,/, based/VBN in/IN 
[ Rahway/NNP ]
,/, 
[ N.J./NNP ]
,/, is/VBZ 
[ the/DT world/NN 's/POS largest/JJS prescription/NN drug/NN company/NN ]
,/, with/IN 
[ a/DT veteran/JJ sales/NNS force/NN ]
and/CC 
[ a/DT strong/JJ record/NN ]
in/IN taking/VBG 
[ drugs/NNS ]
through/IN 
[ clinical/JJ trials/NNS ]
./. 

[ Du/NNP Pont/NNP ]
,/, based/VBN in/IN 
[ Wilmington/NNP ]
,/, 
[ Del./NNP ]
,/, is/VBZ 
[ a/DT major/JJ chemicals/NNS ]
and/CC 
[ energy/NN company/NN ]
./. 

======================================

[ Joseph/NNP A./NN Mollica/NNP ]
,/, 
[ Du/NNP Pont/NNP 's/POS vice/NN president/NN ]
for/IN 
[ pharmaceuticals/NNS ]
,/, noted/VBD that/IN 
[ Merck/NNP 's/POS involvement/NN ]
also/RB ``/`` represents/VBZ 
[ a/DT recognition/NN ]
of/IN 
[ the/DT strength/NN ]
of/IN 
[ our/PRP$ research/NN effort/NN ]
./. 

''/'' Although/IN 
[ several/JJ companies/NNS ]
including/VBG 
[ Merck/NNP ]
have/VBP 
[ research/NN interests/NNS ]
in/IN 
[ angiotensin/NN II/CD receptor/NN antagonists/NNS ]
,/, 
[ a/DT spokesman/NN ]
for/IN 
[ Merck/NNP ]
said/VBD 
[ it/PRP ]
considers/VBZ 
[ Du/NNP Pont/NNP ]
to/TO be/VB leading/VBG 
[ the/DT pack/NN ]
./. 

======================================

[ A/DT Du/NNP Pont/NNP compound/NN ]
has/VBZ just/RB passed/VBN 
[ human/JJ safety/NN trials/NNS ]
and/CC is/VBZ in/IN 
[ early/JJ efficacy/NN trials/NNS ]
./. 

[ Du/NNP Pont/NNP ]
,/, 
[ which/WDT ]
hopes/VBZ to/TO get/VB 
[ marketing/NN clearance/NN ]
by/IN 
[ the/DT mid-1990s/NNS ]
,/, estimates/VBZ that/IN 
[ the/DT alliance/NN ]
with/IN 
[ Merck/NNP ]
could/MD cut/VB 
[ development/NN time/NN ]
for/IN 
[ the/DT compounds/NNS ]
by/IN 
[ two/CD years/NNS ]
./. 

[ The/DT compounds/NNS ]
block/VBP 
[ the/DT action/NN ]
of/IN 
[ a/DT hormone/NN ]
,/, 
[ angiotensin/NN II/CD ]
,/, 
[ which/WDT ]
has/VBZ 
[ a/DT role/NN ]
in/IN 
[ many/JJ cases/NNS ]
of/IN 
[ high/JJ blood/NN pressure/NN ]
./. 

======================================

[ Merck/NNP ]
will/MD lead/VB 
[ the/DT effort/NN ]
to/TO take/VB 
[ the/DT compounds/NNS ]
through/IN 
[ clinical/JJ trials/NNS ]
and/CC 
[ regulatory/JJ reviews/NNS ]
./. 

In/IN 
[ exchange/NN ]
,/, 
[ the/DT company/NN ]
gets/VBZ to/TO share/VB with/IN 
[ Du/NNP Pont/NNP world-wide/JJ marketing/NN responsibilities/NNS ]
and/CC 
[ sales/NNS revenue/NN ]
./. 

======================================

[ The/DT other/JJ marketing/NN accords/NNS ]
comprise/VBP 
[ two/CD Merck/NNP products/NNS ]
with/IN relatively/RB 
[ small/JJ sales/NNS ]
:/: 
[ Sinemet/NNP ]
,/, for/IN 
[ Parkinson/NNP 's/POS disease/NN ]
,/, and/CC 
[ Vaseretic/NNP ]
,/, for/IN 
[ high/JJ blood/NN pressure/NN ]
./. 

[ That/DT arrangement/NN ]
will/MD enable/VB 
[ Merck/NNP ]
,/, 
[ whose/WP$ research/NN pipeline/NN ]
has/VBZ been/VBN paying/VBG 
[ big/JJ dividends/NNS ]
in/IN 
[ recent/JJ years/NNS ]
,/, to/TO free/VB up/RP more/JJR of/IN 
[ its/PRP$ sales/NNS ]
force/NN to/TO concentrate/VB on/IN 
[ other/JJ Merck/NNP products/NNS ]
./. 

For/IN 
[ Du/NNP Pont/NNP 's/POS part/NN ]
,/, 
[ it/PRP ]
gets/VBZ 
[ more/JJR drugs/NNS ]
to/TO sell/VB while/IN 
[ its/PRP$ own/JJ products/NNS ]
are/VBP in/IN 
[ earlier/JJR stages/NNS ]
of/IN 
[ development/NN ]
./. 

======================================

[ Du/NNP Pont/NNP ]
will/MD have/VB 
[ exclusive/JJ marketing/NN rights/NNS ]
to/TO 
[ Sinemet/NNP ]
in/IN 
[ North/NNP America/NNP ]
starting/VBG in/IN 
[ 1990/CD ]
./. 

In/IN 
[ 1988/CD ]
,/, 
[ North/JJ American/JJ sales/NNS ]
of/IN 
[ the/DT drug/NN ]
were/VBD about/IN 
[ $/$ 100/CD million/CD ]
./. 

======================================

[ Du/NNP Pont/NNP ]
will/MD obtain/VB 
[ exclusive/JJ North/JJ American/JJ ]
marketing/NN 
[ rights/NNS ]
to/TO 
[ Vaseretic/NNP ]
starting/VBG in/IN 
[ 1992/CD ]
and/CC will/MD jointly/RB promote/VB 
[ the/DT drug/NN ]
with/IN 
[ Merck/NNP ]
in/IN 
[ certain/JJ European/JJ countries/NNS ]
starting/VBG in/IN 
[ 1990/CD ]
./. 

In/IN 
[ Europe/NNP ]

[ the/DT drug/NN ]
is/VBZ marketed/VBN under/IN 
[ the/DT name/NN Co-Renitec/NNP ]
./. 

[ An/DT industry/NN source/NN ]
estimated/VBD 
[ 1988/CD sales/NNS ]
of/IN 
[ the/DT drug/NN ]
in/IN 
[ Europe/NNP ]
and/CC 
[ North/NNP America/NNP ]
at/IN 
[ $/$ 45/CD million/CD ]
./. 

======================================

[ Michael/NNP Waldholz/NNP ]
in/IN 
[ New/NNP York/NNP ]
contributed/VBD to/TO 
[ this/DT article/NN ]
./. 
